TY - JOUR
T1 - Time-delay when updating infusion rates in the graseby 3400 pump results in reduced drug delivery
AU - Sarraf, Elie
AU - Mandel, Jeff E.
PY - 2014/1
Y1 - 2014/1
N2 - Infusion pumps are commonly used for infusion of drugs for physiologic control, and infusion rate has been demonstrated to affect the parameters of pharmacokinetic models. In attempting to develop a model that explained this behavior, we examined the behavior of the Graseby 3400 syringe pump under a range of flow conditions and with variations in syringe characteristics. Two issues were identified: start-up loss (the difference between actual and ideal delivery on initial infusion) and update loss (the difference between actual and ideal delivery when transmitting a command to change infusion rate). Under worst-case conditions, this may result in a 20-second period of zero delivery during start-up, and when updating infusion rates once per second, zero output. These effects are influenced by syringe characteristics and vary sufficiently as to make it impossible to isolate this effect from the pharmacokinetic process being controlled. The implications of this for previous published results and clinical application of target-controlled infusions are discussed.
AB - Infusion pumps are commonly used for infusion of drugs for physiologic control, and infusion rate has been demonstrated to affect the parameters of pharmacokinetic models. In attempting to develop a model that explained this behavior, we examined the behavior of the Graseby 3400 syringe pump under a range of flow conditions and with variations in syringe characteristics. Two issues were identified: start-up loss (the difference between actual and ideal delivery on initial infusion) and update loss (the difference between actual and ideal delivery when transmitting a command to change infusion rate). Under worst-case conditions, this may result in a 20-second period of zero delivery during start-up, and when updating infusion rates once per second, zero output. These effects are influenced by syringe characteristics and vary sufficiently as to make it impossible to isolate this effect from the pharmacokinetic process being controlled. The implications of this for previous published results and clinical application of target-controlled infusions are discussed.
UR - http://www.scopus.com/inward/record.url?scp=84891789233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891789233&partnerID=8YFLogxK
U2 - 10.1213/01.ane.0000438349.21617.2f
DO - 10.1213/01.ane.0000438349.21617.2f
M3 - Article
AN - SCOPUS:84891789233
SN - 0003-2999
VL - 118
SP - 145
EP - 150
JO - Anesthesia and analgesia
JF - Anesthesia and analgesia
IS - 1
ER -